Archive for the ‘dermatology retractions’ Category
Researchers have agreed to pull a 2015 study exploring whether a plant extract can safeguard tanners from ultraviolet exposure after not obtaining formal approval from an ethics committee.
According to the first author, the problem lay in a misunderstanding – when they originally applied for approval six years ago, the researchers believed they didn’t need to go through a formal approval process, since the compound was commercially available without a prescription. Once they realized their mistake, they chose to retract the paper.
Here’s the retraction note for “Oral Polypodium leucomotos increases the anti-inflammatory and melanogenic responses of the skin to different modalities of sun exposures: a pilot study,” published in Photodermatology Photoimmunology & Photomedicine. Read the rest of this entry »
The paper explicitly noted that the authors do not have any financial conflicts of interest, and that a government program supported the study. According to the journal, a reader alerted them to the conflict of interest.
The cooperate tie wasn’t a secret, though — one of the authors was listed as affiliated with the company, Pharma Research Products, based in Korea.
Here’s the retraction notice for “A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow’s Feet: A New Concept of Regenerative Filler:”
A case report that detailed the removal of a cyst from the side of a young woman’s face has been retracted for plagiarizing text from a similar case report published two years earlier.
Contemporary Clinical Dentistry posted the notice on July 31. Parts of the 2014 report were “directly copied” from a report published in 2012 by the Journal of Oral and Maxillofacial Pathology. Neither of the reports share authors in common.
The notice reads:
The journal is chalking it up to an “administrative error” that caused it to publish a paper that had already appeared in two other outlets.
According to one of the authors, the “most junior” author published the paper in 2008 in the The Egyptian Journal of Hospital Medicine “without informing other authors.”
When first author Ahmad Settin and the other authors sent it to the IJD in 2009, they were told its small sample size made it a letter to the editor; they decided to “decline submission” and send it to to Acta Dermatovenerologica Alpina, Pannonica et Adriatica, where it was published later that year. When Acta discovered the first version, it retracted the paper in 2013.
Meanwhile, editors at the IJD ended up posting the article, “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt,” in 2011 without telling the authors. So they, too, now have to retract it:
In what can only be described as an ironic twist, the Indian Journal of Dermatology is retracting a paper that presents guidelines on plagiarism for…wait for it…
The Journal of Cosmetic and Laser Therapy has retracted a 2014 paper by a group of South Korean researchers after determining that the authors had doubled up on their publishing odds by submitting the manuscript to a competing journal.
The article was titled “A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner’s solution in melasma patients,” and it purported to find that:
This study suggests Jessner’s peel is a safe and effective method in the early course of treatment for melasma when combined with low-fluence 1064-nm Q-switched Nd:YAG laser.
Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs
The Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.
According to the notice, which is behind a paywall (for shame!), the paper appears to have overstated the number of cases the hospital itself has treated of the life-threatening condition: Read the rest of this entry »
A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.
Abdul Razzaque Ahmed was considered something of a miracle worker by his patients, treating two rare and disfiguring skin conditions called pemphigoid and pemphigus vulgaris. He used more powerful medicines than the typical course of treatment, including a drug normally used to treat cancer.
The initial indictment stated that Ahmed mixed blood samples to falsely show a “dual diagnosis” of both diseases, and prove to Medicare that they required the more rigorous (and expensive) treatment. It also alleged that he profited massively from the government pay-outs. He was convicted of obstruction in 2007; the other charges were dropped when he agreed to forfeit assets worth $2.9 million.
Now, a 2001 paper by Ahmed, which claimed fifteen patients had a dual diagnosis, has been retracted because the samples were all mixed. Here is the retraction notice from Clinical Immunology: Read the rest of this entry »
Acta Dermatovenerologica Alpina, Pannonica et Adriatica is retracting the 2009 article “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt” after discovering that they were far from the first publication to print the paper.
Here’s the notice, from Allergy, Asthma, & Clinical Immunology, of a paper titled “Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks:” Read the rest of this entry »